PAR 4.65% 20.5¢ paradigm biopharmaceuticals limited..

FDA decision timeline for phase 3 trials, page-2

  1. 688 Posts.
    lightbulb Created with Sketch. 129
    My understanding is that there is no time requirement this time around, but could normally expect a response within 3 months.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.